Reply letter to the editor concerning the article ‘Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance’

According to the current European medicines legislation, on the labeling is mandatory a warning contraindicating for hereditary fructose intolerance (HFI) patients medicines with oral or parenteral fructose and sorbitol, and oral sucrose, invert sugar, isomaltitol, lactitol and maltitol, but parente...

Descripción completa

Detalles Bibliográficos
Autores principales: Izquierdo-Garcia, Elsa, Alvaro Alonso, Elena Alba, Montero Pastor, Berta, Such Díaz, Ana, Escobar Rodríguez, Ismael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225529/
https://www.ncbi.nlm.nih.gov/pubmed/35358012
http://dx.doi.org/10.1080/21645515.2022.2051414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225529/
https://www.ncbi.nlm.nih.gov/pubmed/35358012
http://dx.doi.org/10.1080/21645515.2022.2051414

Ejemplares similares